• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Hydroxypyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Hydroxypyrimidines

4,6-Dihydroxy-2-methylpyrimidine: A Comprehensive Overview of CAS No. 40497-30-1

4,6-Dihydroxy-2-methylpyrimidine (CAS No. 40497-30-1) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, has garnered considerable attention due to its potential therapeutic properties and its role in the synthesis of various bioactive molecules.

The molecular formula of 4,6-Dihydroxy-2-methylpyrimidine is C₅H₆N₂O₂, and it has a molecular weight of 138.11 g/mol. The compound features a pyrimidine ring with two hydroxyl groups at the 4 and 6 positions and a methyl group at the 2 position. This specific arrangement of functional groups imparts unique chemical and biological properties to the molecule, making it an attractive candidate for various applications.

In recent years, 4,6-Dihydroxy-2-methylpyrimidine has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of interest is its role in the development of antiviral agents. Research has shown that compounds derived from 4,6-Dihydroxy-2-methylpyrimidine exhibit potent antiviral activity against a range of viruses, including herpes simplex virus (HSV) and human immunodeficiency virus (HIV). The mechanism of action involves the inhibition of viral replication through the disruption of key enzymatic processes.

Beyond antiviral applications, 4,6-Dihydroxy-2-methylpyrimidine has also been explored for its potential as an anticancer agent. Studies have demonstrated that derivatives of this compound can induce apoptosis in cancer cells by targeting specific signaling pathways. For instance, a recent study published in the Journal of Medicinal Chemistry reported that a novel derivative of 4,6-Dihydroxy-2-methylpyrimidine showed significant cytotoxicity against breast cancer cells while exhibiting minimal toxicity to normal cells.

The synthetic versatility of 4,6-Dihydroxy-2-methylpyrimidine makes it an ideal starting material for the preparation of a wide range of bioactive molecules. Its reactivity with various functional groups allows for the introduction of diverse substituents, thereby expanding its potential applications. For example, researchers have successfully synthesized derivatives with enhanced solubility and bioavailability by introducing polar or lipophilic groups to the molecule.

In addition to its direct therapeutic applications, 4,6-Dihydroxy-2-methylpyrimidine has also found use as an intermediate in the synthesis of other important pharmaceuticals. Its ability to undergo selective functionalization reactions makes it a valuable building block in organic synthesis. This has led to its incorporation into the production processes of several commercially available drugs.

The safety profile of 4,6-Dihydroxy-2-methylpyrimidine is another critical aspect that has been extensively evaluated. Toxicological studies have shown that the compound is generally well-tolerated at therapeutic doses and does not exhibit significant toxicity in animal models. However, as with any chemical compound, appropriate handling and storage precautions should be observed to ensure safety in laboratory settings.

In conclusion, 4,6-Dihydroxy-2-methylpyrimidine (CAS No. 40497-30-1) is a multifaceted compound with promising applications in medicinal chemistry and pharmaceutical research. Its unique molecular structure and versatile synthetic properties make it an attractive candidate for the development of novel therapeutic agents. Ongoing research continues to uncover new potential uses for this compound, further solidifying its importance in the field.

• 42351-88-2(2-tert-butyl-3,4-dihydropyrimidin-4-one)
• 13566-48-8(4,6-Dimethoxy-2-methylpyrimidine)
• 7314-65-0(4-Methoxy-2-methylpyrimidine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)